Clinical Trials Logo

Vaginitis clinical trials

View clinical trials related to Vaginitis.

Filter by:

NCT ID: NCT00213018 Completed - HIV Infections Clinical Trials

Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission

Start date: October 1999
Phase: Phase 2
Study type: Interventional

The primary aims of the study were to assess the safety and acceptability of Carraguard ™ (PC-515) when applied vaginally at least three times weekly for 6-12 months. Secondary aims were to gather preliminary data on Carraguard's effectiveness in preventing male-to-female transmission of HIV. The hypothesis was that Carraguard would cause little or no significant irritation, including lesions; that women would find Carraguard acceptable. The study was not powered to determine effectiveness, but based on safety, acceptability and feasibility parameters, the outcome of the Phase 2 trial would enable a decision whether or not to proceed to a Phase 3 efficacy trial.

NCT ID: NCT00167921 Completed - Atrophic Vaginitis Clinical Trials

Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis

Start date: October 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with Premarin® oral tablets in postmenopausal women with atrophic vaginitis.

NCT ID: NCT00137371 Completed - Atrophy Clinical Trials

Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis

Start date: August 2005
Phase: Phase 3
Study type: Interventional

This protocol is designed to study the effect and safety of 2 low-dose regimens of conjugated estrogen cream (PVC) given vaginally in postmenopausal women with atrophic vaginitis.

NCT ID: NCT00108849 Completed - Menopause Clinical Trials

Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

Start date: March 2005
Phase: Phase 3
Study type: Interventional

This trial is conducted in North America. The purpose of this study is to determine if Vagifem Low Dose is an effective and safe treatment for patients suffering from postmenopausal atrophic vaginitis.